StreetInsider.com News Articles

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has closed its previously disclosed transaction pursuant to a Securities Purchase Agreement (“SPA”) with an institutional investor for the exchange of $200 million of common stock of its majority owned subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC: SMNR, SMNRW), held by Scilex for $200 million in Bitcoin (BTC), representing

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc

Thu, 25 Sep 2025 06:00:00 -0400

Scilex agrees to exchange $200 million Semnur stock for bitcoin

Tue, 23 Sep 2025 10:00:43 -0400

Scilex Holding Company (NASDAQ: SCLX) signed a securities purchase agreement with an institutional investor to exchange $200 million of common stock in its majority-owned subsidiary Semnur Pharmaceuticals (OTC: SMNR, SMNRW) for $200 million in bitcoin.

The institutional investor will purchase 12.5 million shares of Semnur common stock held by Scilex for $16.00 per share. The transaction is subject to customary closing conditions and is expected to close on or about September 23, 2025.

Scilex has engaged Biconomy.com to collaborate on cryptocurrency strategies including reserve build up, treasury management, and strategy implementation. "I am very excited to work with Scilex on their next

Scilex agrees to exchange $200 million Semnur stock for bitcoin

Tue, 23 Sep 2025 10:00:43 -0400

Scilex agrees to exchange $200 million Semnur stock for bitcoin

Tue, 23 Sep 2025 10:00:43 -0400

Scilex agrees to exchange $200 million Semnur stock for bitcoin

Tue, 23 Sep 2025 10:00:43 -0400

Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holdi

Tue, 23 Sep 2025 10:00:00 -0400

PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has signed a Securities Purchase Agreement (“SPA”) with the institutional investor to exchange $200 million of common stock of its majority owned subsidiary, Semnur Pharmaceuticals, Inc. (“Semnur”) (OTC: SMNR, SMNRW), held by Scilex for $200 million in Bitcoin (BTC).